TTP develops from absence or inactivation of the ADAMTS13, leading to the accumulation of vWF multimers and the formation of microvascular thrombi with ischemic end-organ damage (57, 82). The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.